Inhibition of Bcl-6 Expression Ameliorates Asthmatic Characteristics in Mice
- PMID: 38277017
- DOI: 10.1007/s11596-023-2800-z
Inhibition of Bcl-6 Expression Ameliorates Asthmatic Characteristics in Mice
Abstract
Objective: The function of Bcl-6 in T follicular helper (Tfh) cell maturation is indispensable, and Tfh cells play a pivotal role in asthma. This study investigated the impact of Bcl-6 on asthmatic traits.
Methods: The microscopic pathological alterations, airway resistance (AR), and lung compliance (LC) were determined in asthmatic mice and Bcl-6 interference mice. The surface molecular markers of Tfh cells and the Bcl-6 mRNA and protein expression were determined by flow cytometry, RT-qPCR, and Western blotting, respectively. The relationships between the Tfh cell ratio and the IgE and IgG1 concentrations in peripheral blood mononuclear cells (PBMCs) and bronchoalveolar lavage fluid (BALF) were determined.
Results: Asthmatic inflammatory changes were observed in the lung tissue and were attenuated by Bcl-6 siRNA and dexamethasone (DXM). Asthmatic mice exhibited an increased AR and a decreased LC, while Bcl-6 siRNA or DXM mitigated these changes. The percentages of Tfh cells and eosinophils were significantly increased in the asthmatic mice, and they significantly decreased after Bcl-6 inhibition or DXM treatment. RT-qPCR and Western blotting analyses revealed that the Bcl-6 expression level in PBMCs was significantly higher in asthmatic mice, and it decreased following Bcl-6 inhibition or DXM treatment. The IgE expression in the serum and BALF and the B cell expression in PBMCs exhibited a similar trend. In asthmatic mice, the ratio of Tfh cells in the peripheral blood showed a strong positive correlation with the IgE levels in the serum and BALF, but not with the IgG1 levels.
Conclusion: The amelioration of airway inflammation and airway hyper-responsiveness is achieved through Bcl-6 suppression, which effectively hinders Tfh cell differentiation, ultimately resulting in a concurrent reduction in IgE production.
Keywords: Bcl-6; Tfh; airway hyper-responsiveness; asthma; mouse model.
© 2024. Huazhong University of Science and Technology.
Similar articles
-
[Pathogenic mechanism of CD8(+)CD28(-)T cell and the effect of dexamethasone in asthmatic mouse].Zhonghua Yi Xue Za Zhi. 2011 Jul 12;91(26):1861-5. Zhonghua Yi Xue Za Zhi. 2011. PMID: 22093792 Chinese.
-
Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice: Iristectorigenin A ameliorates asthma phenotype.Phytomedicine. 2022 Sep;104:154252. doi: 10.1016/j.phymed.2022.154252. Epub 2022 Jun 8. Phytomedicine. 2022. PMID: 35752075
-
Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung.Allergol Int. 2021 Jul;70(3):351-359. doi: 10.1016/j.alit.2021.01.008. Epub 2021 Mar 3. Allergol Int. 2021. PMID: 33674189
-
Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.Front Immunol. 2021 Nov 5;12:747730. doi: 10.3389/fimmu.2021.747730. eCollection 2021. Front Immunol. 2021. PMID: 34804031 Free PMC article.
-
[Effects of fasudil on the expression of Rho kinase-1 and airway inflammation in a mouse model of asthma.].Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):847-9. Zhonghua Jie He He Hu Xi Za Zhi. 2009. PMID: 20079297 Chinese.
Cited by
-
Inhibitior of Bcl6 by FX1 protects DSS induced colitis mice through anti-inflammatory effects.Front Immunol. 2025 May 9;16:1558845. doi: 10.3389/fimmu.2025.1558845. eCollection 2025. Front Immunol. 2025. PMID: 40416976 Free PMC article.
-
B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.Int J Mol Sci. 2024 Oct 11;25(20):10968. doi: 10.3390/ijms252010968. Int J Mol Sci. 2024. PMID: 39456751 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials